biologic

Vistaseal

Fibrin Sealant (Human)

Loss of exclusivityNovember 2029projected — 12-year biologic exclusivity estimate
CompanyInstituto Grifols, S.A.

Drug detail

Brand nameVistaseal
Active ingredientFibrin Sealant (Human)
Strength6ML
Dosage formFrozen
RouteTopical
ModalityBiologic
FDA approvalNovember 2017
Marketing statusRx

Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.

Not found